News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News Don't cut prices, cut taxes, pharma CEO tells Trump Industry plays key role in job creation too, says Novartis CEO.
News NICE recommends Novartis kidney cancer drug Afinitor finally recommended after rejection in 2011.
News Trump pledges 'bidding' to cut drug prices, stocks tumble Donald Trump’s first press conference of the year may have been farcical at times, as he fought off salacious allegations about his links with Russia, but the president-elect's attack on dr
News Trump 'already understands' need to incentivise R&D, says Me... Frazier takes swipe at price-hiking generics firms.
US Vericel hopes for US hit with Maci knee treatment Tissue engineering product previously flopped in EU.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
